Cambridge RNA Therapeutics Startup Undecimal Bio Raises €16 Million to Expand AI-Powered Delivery Platform
Cambridge‑based spin‑out Undecimal Bio secured €16 million in Seed funding, co‑led by 4BIO Capital and IQ Capital, to develop its AI‑driven DELiveri platform that identifies conjugates for precise siRNA delivery to non‑liver tissues, starting with renovascular diseases.